A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

Clinical trial NCT05160805 · COMPLETED

Trial details

NCT number: NCT05160805
Sponsor: ONL Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Open Angle Glaucoma

Start date: 2022-05-02
Primary completion: 2024-04-09
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.